1. |
Yong PF, Thaventhiran JE, Grimbacher B. " A rose is a rose is a rose”, but CVID is not CVID: common variable immune deficiency (CVID), what do we know in 2011?. Adv Immunol, 2011, 111: 47-107.
|
2. |
Azizi G, Rezaei N, Kiaee F, et al. T-cell abnormalities in common variable immunodeficiency. J Investig Allergol Clin Immunol, 2017, 26(4): 233-243.
|
3. |
Yong PF, Workman S, Wahid F, et al. Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency. Clin Immunol, 2008, 127(1): 34-42.
|
4. |
Tak Manesh A, Azizi G, Heydari A, et al. Epidemiology and pathophysiology of malignancy in common variable immunodeficiency?. Allergol Immuno Pathol (Madr), 2017, 45(6): 602-615.
|
5. |
Mooney D, Edgar D, Einarsson G, et al. Chronic lung disease in common variable immune deficiency (CVID): a pathophysiological role for microbial and non-B cell immune factors. Crit Rev Microbiol, 2017, 43(4): 508-519.
|
6. |
Gathman B, Mahlaoui N, Gérard L, et al. Clinical picture and treatment of 2212 patients with CVID. J Allergy Clin Immunol, 2014, 134(1): 116-126.
|
7. |
Resnick ES, Moshier EL, Godbold JH, et al. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood, 2012, 119(7): 1650-1657.
|
8. |
Kumar Y, Bhatia A. Common variable immunodeficiency in adults: current diagnostic protocol and laboratory measures. Expert Rev Clin Immunol, 2013, 9(10): 959-977.
|
9. |
Lucena JM, Burillo SS, Núñez RA, et al. Incidence of the C104R TACI mutation in patients with primary antibody deficiency. J Investig Allergol Clin Immunol, 2015, 25(5): 378-379.
|
10. |
Yu JE, Knight AK, Radigan L, et al. Toll-like receptor 7 and 9 defects in common variable immunodeficiency. Allergy Clin Immunol, 2009, 124(2): 349-356.
|
11. |
Azizi G, Abolhassani H, Asgardoon MH, et al. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol, 2017, 13(2): 101-115.
|
12. |
Touw CM, van de Ven AA, de Jong PA, et al. Detection of pulmonary complications in conlnlon variable immunodeficiency. Pediatr Allergy Immunol, 2010, 21(5): 793-805.
|
13. |
Agondi RC, Barros MT, Rizzo LV, et al. Allergic asthma in patients with common variable immunodeficiency. Allergy, 2010, 65(4): 510-515.
|
14. |
Malamut G, Ziol M, Suarez F, et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol, 2008, 48(1): 74-82.
|
15. |
Ameratunga R, Woon ST, Gillis D, et al. New diagnostic criteria for CVID. Expert Rev Clin Immunol, 2014, 10(2): 183-186.
|
16. |
Jolles S, Chapel H, Litzman J. When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach. Clin Exp Immunol, 2017, 188(3): 333-341.
|
17. |
Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract, 2016, 4(1): 38-59.
|
18. |
Vettukattil JJ. Pathogenesis of pulmonary arteriovenous malformations: role of hepatopulmonary interactions. Heart, 2002, 88(6): 561-563.
|
19. |
Takahashi N, Matsumoto K, Saito H, et al. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients. J Immunol, 2009, 82(9): 5515-5527.
|
20. |
Malphettes M, Gerard L, Carmagnat M, et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis, 2009, 49(9): 1329-1338.
|
21. |
Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immun, 1999, 92(1): 34-48.
|
22. |
Cooper MA, Pommcring TL, Koranyi K. Primary immunodeficiencies. Am Fam Physician, 2003, 68(10): 2001-2008.
|